Clearmind Medicine (CMND) Competitors $0.86 -0.01 (-0.80%) As of 09:36 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CMND vs. CASI, FLGC, GELS, ABP, BFRG, ACXP, EDSA, XFOR, ASBP, and PRPHShould you be buying Clearmind Medicine stock or one of its competitors? The main competitors of Clearmind Medicine include CASI Pharmaceuticals (CASI), Flora Growth (FLGC), Gelteq (GELS), Abpro (ABP), Bullfrog AI (BFRG), Acurx Pharmaceuticals (ACXP), Edesa Biotech (EDSA), X4 Pharmaceuticals (XFOR), Aspire Biopharma (ASBP), and ProPhase Labs (PRPH). These companies are all part of the "pharmaceutical products" industry. Clearmind Medicine vs. Its Competitors CASI Pharmaceuticals Flora Growth Gelteq Abpro Bullfrog AI Acurx Pharmaceuticals Edesa Biotech X4 Pharmaceuticals Aspire Biopharma ProPhase Labs Clearmind Medicine (NASDAQ:CMND) and CASI Pharmaceuticals (NASDAQ:CASI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations. Which has more volatility and risk, CMND or CASI? Clearmind Medicine has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. Comparatively, CASI Pharmaceuticals has a beta of 0.54, meaning that its stock price is 46% less volatile than the S&P 500. Does the media prefer CMND or CASI? In the previous week, Clearmind Medicine had 11 more articles in the media than CASI Pharmaceuticals. MarketBeat recorded 12 mentions for Clearmind Medicine and 1 mentions for CASI Pharmaceuticals. CASI Pharmaceuticals' average media sentiment score of 1.87 beat Clearmind Medicine's score of 0.27 indicating that CASI Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Clearmind Medicine Neutral CASI Pharmaceuticals Very Positive Which has better valuation & earnings, CMND or CASI? Clearmind Medicine has higher earnings, but lower revenue than CASI Pharmaceuticals. Clearmind Medicine is trading at a lower price-to-earnings ratio than CASI Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClearmind MedicineN/AN/A-$5.26M-$1.10-0.79CASI Pharmaceuticals$28.54M0.58-$39.26M-$2.55-0.52 Do analysts prefer CMND or CASI? CASI Pharmaceuticals has a consensus target price of $4.00, indicating a potential upside of 199.63%. Given CASI Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe CASI Pharmaceuticals is more favorable than Clearmind Medicine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00CASI Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is CMND or CASI more profitable? Clearmind Medicine has a net margin of 0.00% compared to CASI Pharmaceuticals' net margin of -129.05%. Clearmind Medicine's return on equity of -164.79% beat CASI Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Clearmind MedicineN/A -164.79% -71.12% CASI Pharmaceuticals -129.05%-972.55%-77.33% Do insiders and institutionals have more ownership in CMND or CASI? 96.1% of Clearmind Medicine shares are owned by institutional investors. Comparatively, 22.2% of CASI Pharmaceuticals shares are owned by institutional investors. 21.2% of CASI Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryClearmind Medicine beats CASI Pharmaceuticals on 8 of the 15 factors compared between the two stocks. Get Clearmind Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for CMND and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CMND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CMND vs. The Competition Export to ExcelMetricClearmind MedicineMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.69M$2.43B$5.48B$8.94BDividend YieldN/A1.79%5.38%4.12%P/E Ratio-0.798.7826.2219.74Price / SalesN/A636.32394.92109.12Price / CashN/A154.3736.4957.06Price / Book1.604.467.915.37Net Income-$5.26M$31.16M$3.15B$248.34M7 Day Performance-3.88%0.38%0.75%1.67%1 Month Performance-8.17%8.14%3.46%4.56%1 Year Performance-45.25%3.02%34.60%18.42% Clearmind Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CMNDClearmind Medicine0.5953 of 5 stars$0.87-0.8%N/A-47.5%$3.69MN/A-0.79N/ACASICASI Pharmaceuticals4.5843 of 5 stars$1.35+9.3%$4.00+197.4%-75.4%$15.13M$28.54M-0.53180Positive NewsFLGCFlora Growth2.9861 of 5 stars$0.67+1.5%$4.00+496.9%-39.4%$14.90M$53.26M-0.68280News CoveragePositive NewsGELSGelteqN/A$1.69+7.6%N/AN/A$14.82M$100K0.00N/AGap DownABPAbproN/A$0.21-9.7%$4.00+1,777.9%N/A$14.35M$180K0.0015News CoveragePositive NewsBFRGBullfrog AI1.2209 of 5 stars$1.60+5.3%N/A-8.3%$14.31M$60K-1.984Gap UpACXPAcurx Pharmaceuticals2.7962 of 5 stars$0.63+4.6%$8.00+1,169.8%-77.1%$14.15MN/A-0.903Positive NewsEDSAEdesa Biotech1.7419 of 5 stars$2.00flat$21.00+950.0%-53.8%$14.05MN/A-1.2620Positive NewsXFORX4 Pharmaceuticals4.8364 of 5 stars$2.30-5.0%$72.33+3,044.9%-89.5%$14.01M$2.56M1.0780High Trading VolumeASBPAspire BiopharmaN/A$0.27-3.4%N/AN/A$13.96MN/A0.00N/APositive NewsGap UpPRPHProPhase Labs0.9154 of 5 stars$0.35+4.4%N/A-90.6%$13.92M$6.77M-0.28130News CoverageGap Down Related Companies and Tools Related Companies CASI Competitors FLGC Competitors GELS Competitors ABP Competitors BFRG Competitors ACXP Competitors EDSA Competitors XFOR Competitors ASBP Competitors PRPH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CMND) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearmind Medicine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearmind Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
